Is There Evidence for Symptoms of Cannabis Withdrawal in the National Epidemiologic Survey of Alcohol and Related Conditions?

REFERENCES

• Compton W M, Grant B F, Colliver J D, Glantz M D, Stinson F S. Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. JAMA. 2004; 291: 2114–2121
   PubMed Web of Science ®Google Scholar
• Wallace J M, Jr, Bachman J G, O'Malley P M, Johnston L D, Schulenberg J E, Cooper S M. Tobacco, alcohol, and illicit drug use: racial and ethnic differences among U.S. high school seniors, 1976–2000. Public Health Rep 2002; 117(Suppl. 1)S67–S75
   PubMed Web of Science ®Google Scholar
• Johnston L D, O'Malley P M, Bachman J G, Schulenberg J E. Teen drug use down but progress halts among youngest teens. University of Michigan News and Information Services, Ann Arbor, Michigan 2005, http://www.monitoringthefuture.org/pressreleases/O5drugpr_complete.pdf Available at. Accessed May 5, 2006
   Google Scholar
• National Institute on Drug Abuse. National Household Survey on Drug Abuse. U.S. Department of Health and Human Services, Washington, D.C. 1991
   Google Scholar
• Fergusson D M, Horwood L J. Cannabis use and dependence in a New Zealand birth cohort. N Z Med J. 2000; 113: 156–158
   PubMed Web of Science ®Google Scholar
• Reid A, Lynskey M, Copeland J. Cannabis use among Australian adolescents: findings of the 1998 National Drug Strategy Household Survey. Aust N Z J Public Health. 2000; 24: 596–602
   PubMed Web of Science ®Google Scholar
• Stinson F S, Ruan W J, Pickering R, Grant B F. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med. 2006; 36: 1447–1460
   PubMed Web of Science ®Google Scholar
• Soellner R. Dependence on cannabis—an everlasting issue. Subst Use Misuse. 2005; 40: 857–867
   PubMed Web of Science ®Google Scholar
• Budney A J. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue?. Addiction 2006; 101(Suppl. 1)125–133
   PubMed Web of Science ®Google Scholar
• Budney A J, Hughes J R, Moore B A, Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry, 2004; 161: 1967–1977
   PubMed Web of Science ®Google Scholar
• Budney A J, Hughes J R. The cannabis withdrawal syndrome. Curr Opin Psychiatry. 2006; 19: 233–238
   PubMed Web of Science ®Google Scholar
• Kouri E M, Pope H G, Jr, Lukas S E. Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology (Berl). 1999; 143: 302–308
   PubMed Web of Science ®Google Scholar
• Kouri E M, Pope H G, Jr. Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol 2000; 8: 483–492
   PubMed Web of Science ®Google Scholar
• Budney A J, Novy P L, Hughes J R. Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction. 1999; 94: 1311–1322
   PubMed Web of Science ®Google Scholar
• Haney M, Ward A S, Comer S D, Hart C L, Foltin R W, Fischman M W. Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology (Berl). 2001; 155: 171–179
   PubMed Web of Science ®Google Scholar
• Haney M, Hart C L, Ward A S, Foltin R W. Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology (Berl). 2003; 165: 157–165
   PubMed Web of Science ®Google Scholar
• Haney M, Comer S D, Ward A S, Foltin R W, Fischman M W. Factors influencing marijuana self-administration by humans. Behav Pharmacol. 1997; 8: 101–112
   PubMedGoogle Scholar
• Hart C L, Haney M, Ward A S, Fischman M W, Foltin R W. Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend. 2002; 67: 301–309
   PubMed Web of Science ®Google Scholar
• Haney M, Ward A S, Comer S D, Foltin R W, Fischman M W. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl). 1999; 141: 395–404
   PubMed Web of Science ®Google Scholar
• Haney M, Ward A S, Comer S D, Foltin R W, Fischman M W. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl). 1999; 141: 385–394
   PubMed Web of Science ®Google Scholar
• Budney A J, Vandrey R G, Hughes J R, Moore B A, Bahrenburg B. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug Alcohol Depend. 2007; 86: 22–29
   PubMed Web of Science ®Google Scholar
• Copersino M L, Boyd S J, Tashkin D P, et al. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict. 2006; 15: 8–14
   PubMed Web of Science ®Google Scholar
• Wiesbeck G A, Schuckit M A, Kalmijn J A, Tipp J E, Bucholz K K, Smith T L. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction. 1996; 91: 1469–1478
   PubMed Web of Science ®Google Scholar
• Cottler L B, Schuckit M A, Helzer J E, et al. The DSM-IV field trial for substance use disorders: major results. Drug Alcohol Depend. 1995; 38: 59–69
   PubMed Web of Science ®Google Scholar
• Budney A J, Moore B A, Vandrey R G, Hughes J R. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003; 112: 393–402
   PubMed Web of Science ®Google Scholar
• Young S E, Corley R P, Stallings M C, Rhee S H, Crowley T J, Hewitt J K. Substance use, abuse and dependence in adolescence: prevalence, symptom profiles and correlates. Drug Alcohol Depend. 2002; 68: 309–322
   PubMed Web of Science ®Google Scholar
• Amos A, Wiltshire S, Bostock Y, Haw S, McNeill A. “You can't go without a fag…you need it for your hash”—a qualitative exploration of smoking, cannabis and young people. Addiction. 2004; 99: 77–81
   PubMed Web of Science ®Google Scholar
• Patton G C, Coffey C, Carlin J B, Sawyer S M, Lynskey M. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction. 2005; 100: 1518–1525
   PubMed Web of Science ®Google Scholar
• Hughes J R. Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine Tob Res. 2007; 9: 329–339
   PubMed Web of Science ®Google Scholar
• Tsuang M T, Bar J L, Harley R M, Lyons M J. The Harvard Twin Study of Substance Abuse: what we have learned. Harv Rev Psychiatry. 2001; 9: 267–279
   PubMed Web of Science ®Google Scholar
• Kendler K S, Prescott C A. Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry. 1998; 155: 1016–1022
   PubMed Web of Science ®Google Scholar
• Han C, McGue M K, Iacono W G. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. Addiction. 1999; 94: 981–993
   PubMed Web of Science ®Google Scholar
• McGue M, Elkins I, Iacono W G. Genetic and environmental influences on adolescent substance use and abuse. Am J Med Genet. 2000; 96: 671–677
   PubMed Web of Science ®Google Scholar
• Maes H H, Woodard C E, Murrelle L, et al. Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: the Virginia Twin Study of Adolescent Behavioral Development. J Stud Alcohol. 1999; 60: 293–305
   PubMed Web of Science ®Google Scholar
• Agrawal A, Lynskey M T. The genetic epidemiology of cannabis use, abuse and dependence: a review. Addiction. 2006; 101: 801–812
   PubMed Web of Science ®Google Scholar
• Lynskey M T, Heath A C, Nelson E C, et al. Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychol Med. 2002; 32: 195–207
   PubMed Web of Science ®Google Scholar
• Neale M C, Harvey E, Maes H H, Sullivan P F, Kendler K S. Extensions to the modeling of initiation and progression: applications to substance use and abuse. Behav Genet. 2006; 36: 507–524
   Google Scholar
• Heath A C, Martin N G, Lynskey M T, Todorov A A, Madden P A. Estimating two-stage models for genetic influences on alcohol, tobacco or drug use initiation and dependence vulnerability in twin and family data. Twin Res. 2002; 5: 113–124
   Google Scholar
• Kendler K S, Neale M C, Sullivan P, Corey L A, Gardner C O, Prescott C A. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med. 1999; 29: 299–308
   PubMed Web of Science ®Google Scholar
• Agrawal A, Neale M, Jacobson K, Prescott C A, Kendler K S. Illicit drug use and abuse/dependence: modeling of two-stage variables using the CCC approach. Addict Behav. 2005; 30: 1043–1048
   Google Scholar
• Grant B F, Kaplan K, Shepard J, Moore T. Source and Accuracy Statement for Wave 1 of the 2001–2002 of the National Epidemiologic Survey on Alcohol and Related Conditions. National Institute on Alcohol Abuse and Alcoholism, Bethesda, Md. 2003
   Google Scholar
• Grant B F, Dawson D A, Stinson F S, Chou P S, Kay W, Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule–IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003; 71: 7–16
   PubMed Web of Science ®Google Scholar
• SAS Institute SAS User Guide, Version 8.2. SAS Institute Inc., Cary, NC 1999
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Lynskey M T, Agrawal A. Psychometric properties of DSM assessments of illicit drug abuse and dependence: Results from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). Psychol Med. 2007; 4: 1–11
   Google Scholar
• Agrawal A, Lynskey M T. Does gender contribute to heterogeneity in criteria for cannabis abuse and dependence? results from the National Epidemiological Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2007; 88: 300–307
   PubMed Web of Science ®Google Scholar
• Teesson M, Lynskey M, Manor B, Baillie A. The structure of cannabis dependence in the community. Drug Alcohol Depend. 2002; 68: 255–262
   PubMed Web of Science ®Google Scholar
• Swift W, Hall W, Teesson M. Characteristics of DSM-IV and ICD-10 cannabis dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing. Drug Alcohol Depend. 2001; 63: 147–153
   PubMedGoogle Scholar
• Gillespie N A, Neale M C, Prescott C A, et al. Factor and item-response analysis of DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opiates. Addiction 2007; 102: 920–930
   PubMed Web of Science ®Google Scholar
• Nelson C B, Rehm J, Ustun T B, Grant B, Chatterji S. Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction. 1999; 94: 843–855
   PubMed Web of Science ®Google Scholar
• Morgenstern J, Langenbucher J, Labouvie E W. The generalizability of the dependence syndrome across substances: an examination of some properties of the proposed DSM-IV dependence criteria. Addiction. 1994; 89: 1105–1113
   PubMed Web of Science ®Google Scholar
• Langenbucher J, Labouvie E W, Martin C, et al. An application of item response theory analysis to alcohol, cannabis and cocaine criteria in DSM-IV. J Abnorm Psychol. 2004; 113: 72–80
   PubMed Web of Science ®Google Scholar
• Sullivan P F, Kendler K S. The genetic epidemiology of smoking. Nicotine Tob Res 1999; 1(Suppl. 2)S51–S57
   PubMedGoogle Scholar
• Madden P A, Heath A C, Pedersen N L, Kaprio J, Koskenvuo M J, Martin N G. The genetics of smoking persistence in men and women: a multicultural study. Behav Genet. 1999; 29: 423–431
   PubMed Web of Science ®Google Scholar
• Madden P A, Pedersen N L, Kaprio J, Koskenvuo M J, Martin N G. The epidemiology and genetics of smoking initiation and persistence: crosscultural comparisons of twin study results. Twin Res. 2004; 7: 82–97
   Google Scholar
• Vink J M, Willemsen G, Boomsma D I. Heritability of smoking initiation and nicotine dependence. Behav Genet. 2005; 35: 397–406
   PubMed Web of Science ®Google Scholar
• Kaprio J, Hammar N, Koskenvuo M, Floderus-Myrhed B, Langinvainio H, Sarna S. Cigarette smoking and alcohol use in Finland and Sweden: a cross-national twin study. Int J Epidemiol. 1982; 11: 378–386
   PubMed Web of Science ®Google Scholar
• Le M M, Koob G F. Drug addiction: pathways to the disease and pathophysiological perspectives. Eur Neuropsychopharmacol. 2007; 17: 377–393
   Google Scholar
• Bierut L J, Dinwiddie S H, Begleiter H, et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry. 1998; 55: 982–988
   PubMed Web of Science ®Google Scholar
• Merikangas K R, Stolar M, Stevens D E, et al. Familial transmission of substance use disorders. Arch Gen Psychiatry. 1998; 55: 973–979
   PubMed Web of Science ®Google Scholar
• Kendler K S, Jacobson K C, Prescott C A, Neale M C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry. 2003; 160: 687–695
   PubMed Web of Science ®Google Scholar
• Kendler K S, Prescott C A, Myers J, Neale M C. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch Gen Psychiatry. 2003; 60: 929–937
   PubMed Web of Science ®Google Scholar
• Pergadia M L, Heath A C, Martin N G, Madden P A. Genetic analysis of DSM-IV nicotine withdrawal in adult twins. Psychol Med. 2006; 36: 963–972
   PubMedGoogle Scholar